Christoph U. Correll, MD | Psychiatrist.com

Article

Strategies for Dosing and Switching Antipsychotics for Optimal Clinical Management

February 28, 2008

Peter F. Buckley, Christoph U. Correll

ASCP Corner

Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 2: Methodological Considerations

September 17, 2007

Christoph U. Correll

ASCP Corner

Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 1: Challenges and Developments

August 15, 2007

Christoph U. Correll

Original Research

Can Antidepressants Be Used to Treat the Schizophrenia Prodrome? Results of a Prospective, Naturalistic Treatment Study of Adolescents

April 16, 2007

Barbara A. Cornblatt, Todd Lencz, Christopher W. Smith, et al

Original Research

Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs.

April 15, 2006

Christoph U. Correll, Anne M. Frederickson, John M. Kane, et al

ASCP Corner

Real-Life Switching Strategies With Second-Generation Antipsychotics

January 16, 2006

Christoph U. Correll

ASCP Corner

Real-Life Dosing With Second-Generation Antipsychotics

December 15, 2005

Christoph U. Correll

ASCP Corner

Metabolic Side Effects of Second-Generation Antipsychotics in Children and Adolescents: A Different Story?

October 14, 2005

Christoph U. Correll

Commentary

Metabolic Effects of Treatment With Atypical Antipsychotics

November 1, 2004

John M. Kane, Eugene J. Barrett, Daniel E. Casey, et al

« 1 … 8 9 10